Form 8-K - Current report:
SEC Accession No. 0001213900-24-083408
Filing Date
2024-09-30
Accepted
2024-09-30 16:49:36
Documents
20
Period of Report
2024-09-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0215863-8k_pasithea.htm   iXBRL 8-K 42227
2 FORM OF PRE-FUNDED WARRANT ea021586301ex4-1_pasithea.htm EX-4.1 94328
3 FORM OF WARRANT ea021586301ex4-2_pasithea.htm EX-4.2 96804
4 FORM OF PLACEMENT AGENT WARRANT ea021586301ex4-3_pasithea.htm EX-4.3 94367
5 FORM OF SECURITIES PURCHASE AGREEMENT ea021586301ex10-1_pasithea.htm EX-10.1 239463
6 FORM OF REGISTRATION RIGHTS AGREEMENT ea021586301ex10-2_pasithea.htm EX-10.2 140217
7 PRESS RELEASE, DATED SEPTEMBER 26, 2024 ea021586301ex99-1_pasithea.htm EX-99.1 8997
  Complete submission text file 0001213900-24-083408.txt   1112641

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE ktta-20240926.xsd EX-101.SCH 3810
9 XBRL DEFINITION FILE ktta-20240926_def.xml EX-101.DEF 26681
10 XBRL LABEL FILE ktta-20240926_lab.xml EX-101.LAB 36819
11 XBRL PRESENTATION FILE ktta-20240926_pre.xml EX-101.PRE 25305
22 EXTRACTED XBRL INSTANCE DOCUMENT ea0215863-8k_pasithea_htm.xml XML 5937
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

EIN.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 241340089
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)